MedPath

Randomized controlled trial of febuxostat and allopurinol on chronic heart failure patients with hyperuricemia

Not Applicable
Conditions
Chronic heart failure with hyperuricemia
Registration Number
JPRN-UMIN000009817
Lead Sponsor
Deaprtment of Cardiovascular Medicine, Fukushima Medical University.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
263
Inclusion Criteria

Not provided

Exclusion Criteria

1.Acute heart failure patients or acute myocardial infarction patients 2.Patients with renal failure (over Cr 2.0 mg/dl) 3.Patients who had already anti-hyperuricemic drug 4.Patietns with hypersensitivity of study drug 5.Pregnant woman

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiac death and rehospitalization due to worsening heart failure
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath